Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

227 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q4 2024.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68.6M shares of 84.8M outstanding shares and own 80.9% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.39M shares), NEA Management Company, LLC (5.58M shares), Frazier Life Sciences Management, L.P. (3.38M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.13M shares), MAVERICK CAPITAL LTD (3.13M shares), WELLINGTON MANAGEMENT GROUP LLP (3.03M shares), Vivo Capital, LLC (2.28M shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (1.9M shares), JENNISON ASSOCIATES LLC (1.89M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.83M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.